CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-01 | Metzger Michael A President and COO | Option exercise · Stock Options (Right to buy) | −15,000 | 0 | ||
| 2021-01-31 | Morrison Briggs Chief Executive Officer | Other acquisition | +1,771 | $12.00 | $21K | 48,336 |
| 2021-01-31 | Meyers Michael L. SVP, Chief Medical Officer | Other acquisition | +1,771 | $12.00 | $21K | 15,166 |
| 2020-12-01 | Metzger Michael A President and COO | Option exercise | +15,000 | $7.20 | $108K | 32,659 |
| 2020-12-01 | Metzger Michael A President and COO | Sale | −15,000 | $22.97 | $345K | 17,659 |
| 2020-12-01 | Metzger Michael A President and COO | Option exercise · Employee Stock Option (right to buy) | −15,000 | 0 | ||
| 2020-11-23 | Ordentlich Peter Chief Scientific Officer | Option exercise | +24,288 | $3.08 | $75K | 24,288 |
| 2020-11-23 | Ordentlich Peter Chief Scientific Officer | Option exercise | +5,684 | $3.08 | $18K | 29,972 |
| 2020-11-23 | Ordentlich Peter Chief Scientific Officer | Sale | −5,684 | $23.33 | $133K | 24,288 |
| 2020-11-23 | Ordentlich Peter Chief Scientific Officer | Sale | −7,954 | $23.58 | $188K | 16,334 |
| 2020-11-23 | Ordentlich Peter Chief Scientific Officer | Sale | −16,334 | $22.89 | $374K | 0 |
| 2020-11-23 | Ordentlich Peter Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −24,288 | 0 | ||
| 2020-11-23 | Ordentlich Peter Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −5,684 | 0 | ||
| 2020-11-10 | Morrison Briggs Chief Executive Officer | Option exercise | +17,466 | $7.20 | $126K | 64,031 |
| 2020-11-10 | Morrison Briggs Chief Executive Officer | Sale | −17,466 | $20.06 | $350K | 46,565 |
| 2020-11-10 | Morrison Briggs Chief Executive Officer | Option exercise · Stock Options (Right to buy) | −17,466 | 0 | ||
| 2020-11-09 | Morrison Briggs Chief Executive Officer | Option exercise | +62,938 | $7.20 | $453K | 109,503 |
| 2020-11-09 | Morrison Briggs Chief Executive Officer | Sale | −62,938 | $20.04 | $1.3M | 46,565 |
| 2020-11-09 | Morrison Briggs Chief Executive Officer | Option exercise · Stock Options (Right to buy) | −62,938 | 0 | ||
| 2020-11-04 | Metzger Michael A President and COO | Option exercise | +100,000 | $7.20 | $720K | 117,659 |
Page 21 of 25 · 500 trades